(Q28334035)
Statements
A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer (English)
D J Perez
V J Harvey
C H Atkinson
P J Dady
A R Kirk
B D Evans
1 December 1991